BlackRock Global Funds - World Healthscience Fund A2 CNH HedgedRegister to Unlock Ratings |
Performance History | 31/07/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
![]() | Fund | 20.0 | 20.6 | -2.0 | -9.2 | 8.0 |
![]() | +/-Cat | - | - | - | - | - |
![]() | +/-B’mrk | - | - | - | - | - |
Category: Other Equity | ||||||
Category Benchmark: - |
Key Stats | ||
NAV 14/08/2024 | CNH 205.50 | |
Day Change | 0.43% | |
Morningstar Category™ | Other Equity | |
ISIN | LU1254117382 | |
Fund Size (Mil) 31/07/2024 | USD 14460.66 | |
Share Class Size (Mil) 13/08/2024 | CNY 981.56 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 09/02/2023 | 1.79% |
Investment Objective: BlackRock Global Funds - World Healthscience Fund A2 CNH Hedged |
The Fund seeks to maximise total return and invest in a manner consistent with the principles of environmental, social and governance (“ESG”) investing. The Fund invests globally at least 70% of its total assets in the equity securities of companies whose predominant economic activity is in healthcare, pharmaceuticals, medical technology and supplies and the development of biotechnology. Currency exposure is flexibly managed. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Xiang Liu 01/06/2020 | ||
Erin Xie 01/04/2011 | ||
Inception Date 15/07/2015 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI World/Health Care NR USD | - |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for BlackRock Global Funds - World Healthscience Fund A2 CNH Hedged | 30/06/2024 |
|
|
Top 5 Holdings | Sector | % |
![]() | ![]() | 8.24 |
![]() | ![]() | 7.67 |
![]() | ![]() | 5.91 |
![]() | ![]() | 4.39 |
![]() | ![]() | 4.04 |
![]() | ||
![]() ![]() ![]() | ||
BlackRock Global Funds - World Healthscience Fund A2 CNH Hedged |